Showing results (91-100 of 292) with videos related to
Sort By:
Pageof 30
Journal of Cardiac Failure|June 1, 1995
Vesnarinone: a new inotropic agent for treating congestive heart failureE Cavusoglu, W H Frishman, M KlapholzDrugs|November 7, 1999
How to use calcium antagonists in hypertension: putting the JNC-VI guidelines into practice. Joint National Committee for the Prevention, Detection, Evaluation and Treatment of High Blood PressureV Singh, J Christiana, W H FrishmanJournal of Clinical Pharmacology|November 10, 1998
Sodium ion/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischemia and reperfusion injuryJ Levitsky, D Gurell, W H FrishmanJournal of Clinical Pharmacology|October 1, 1995
Insulin resistance in systemic hypertension: pharmacotherapeutic implicationsS Mediratta, A Fozailoff, W H FrishmanDrugs|February 1, 1983
Calcium antagonists. Clinical use in the treatment of systemic hypertensionC Spivack, S Ocken, W H FrishmanThe Medical Clinics of North America|March 1, 1989
Beta-adrenergic blocking drugs in the treatment of congestive heart failureS Charlap, E Lichstein, W H FrishmanJournal of Clinical Pharmacology|June 1, 1989
Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind studyW H Frishman, W Shapiro, S CharlapHeart Disease (Hagerstown, Md.)|April 27, 2002
Inhibition of myocardial apoptosis as a therapeutic target in cardiovascular disease prevention: focus on caspase inhibitionN Guttenplan, C Lee, W H FrishmanHeart Disease (Hagerstown, Md.)|April 27, 2002
Tobacco smoking, nicotine, and nicotine and non-nicotine replacement therapiesW H Frishman, T Ky, A IsmailHeart Disease (Hagerstown, Md.)|April 27, 2002
Vasopeptidase inhibitors, neutral endopeptidase inhibitors, and dual inhibitors of angiotensin-converting enzyme and neutral endopeptidaseJ Nawarskas, V Rajan, W H FrishmanPageof 30